Patient-specific factors modulate leukocyte response in dimethyl fumarate treated MS patients.

Patient-specific factors modulate leukocyte response in dimethyl fumarate treated MS patients.

OBJECTIVE:Determine if patient-specific factors modulate absolute lymphocyte count (ALC), neutrophil count (ANC), and/or Neutrophile-lymphocyte ratio (NLR) in Dimethyl Fumarate (DMF) treated patients. METHODS:A retrospective study of patients who initiated DMF between 2013-2018. A multicenter study...

Full description

Bibliographic Details
Main Authors: Myla D Goldman, Lauren Dwyer, Rachael Coleman, Min-Woong Sohn, Olaf Stuve
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0228617

Internet

https://doi.org/10.1371/journal.pone.0228617

Similar Items